This study was designed to analyze the clinical characteristics and prognostic value of c-MYC and BCL-2 proteins expression in patients with primary central nervous system diffuse large B-cell lymphoma (PCNS-DLBCL). Here, MYC is linked to diffuse large B-cell lymphoma of the central nervous system.